ArticleHuman molecular genetics2018

In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's disease.

Takeshi Uenaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.